SEC Form 4 · accession 0001487371-17-000195
GenMark Diagnostics, Inc. · GNMK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Anne Williams
Officer — SVP, Human Resources
Period of report
Sep 15, 2017
Accepted (ET)
Sep 15, 2017 · 7:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001487371
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 15, 2017 | S | 38,681 | $9.08 | D | 155,889 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on 8/16/2017.
- F2The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $8.90 to $9.30 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.